secwatch.observer — SEC 8-K summary
======================================

Issuer:     AGIOS PHARMACEUTICALS, INC. (AGIO)
CIK:        0001439222
Form:       8-K
Filed at:   2024-06-20T23:59:59+00:00
Accession:  0001193125-24-164555
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Agios shareholders elect four Class II directors, approve say-on-pay, ratify auditor at 2024 annual meeting
--------------------------------------------------------------------------------

- Elected Kaye Foster (45.8M for, 5.3M withheld), Maykin Ho (46.7M for, 4.4M withheld), Jeffrey Capello (47.8M for, 3.3M withheld), Catherine Owen (45.6M for, 5.5M withheld) as Class II directors.
- Advisory vote on named executive officer compensation approved: 48.0M for, 3.1M against, 13,404 abstaining.
- Ratified PricewaterhouseCoopers LLP as independent auditor: 52.3M for, 70,843 against, 2,396 abstaining.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1439222/000119312524164555/0001193125-24-164555-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1439222/000119312524164555/d645924d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-164555

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer